Jubilant Pharmova Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Profit before tax

79.34

82.25

273.17

298.84

183.43

Net cashflow-operating activity

-65.12

-3.55

608.38

316.76

181.74

Net cash used in investing activity

31.07

93.10

177.96

-197.71

-284.79

Netcash used in fin. activity

22.51

-107.37

-781.65

-41.05

85.28

Net inc/dec in cash and equivlnt

-11.53

-17.82

4.69

78.00

-17.77

Cash and equivalnt begin of year

22.53

40.33

35.64

18.70

36.47

Cash and equivalnt end of year

10.99

22.51

40.33

96.70

18.70